Our second-generation biomaterial, Salmoss HAPS-COL, builds on the osteoconductive properties of our original HAPS product by incorporating Type I collagen to the salmon-derived hydroxyapatite.
Is our first product in development. It is a new and unique non-human, non-mammal derived xenograft. It has no conflict with kosher or halal communities and is free of bovine prion disease. It favors cyclic economy while creating a positive environmental impact.
We harness the power of science to transform ideas into solutions, creating a positive impact on global health and contributing to a sustainable future.
WhatsApp us